Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 2911 AL 2925

Development and validation of a screening assay for the evaluation of putative neuroprotective agents in the treatment of Parkinson's disease

Yong-Kee CJ, Salomonczyk D, Nash JE.

Neurotox Res. 2011 May;19(4):519-26. doi: 10.1007/s12640-010-9174-2. Epub 2010 Apr 2.

Ontogenetic exposure of rats to pre- and post-natal manganese enhances behavioral impairments produced by perinatal 6-hydroxydopamine

Nowak P, Bojanek K, Szkilnik R, Jośko J, Boroń D, Adwent M, Gorczyca P, Kostrzewa RM, Brus R.

Neurotox Res. 2011 May;19(4):536-43. doi: 10.1007/s12640-010-9184-0. Epub 2010 Apr 6.

High risk of sudden death associated with a PRKAG2-related familial Wolff-Parkinson-White syndrome

Zhang LP, Hui B, Gao BR.

J Electrocardiol. 2011 Jul-Aug;44(4):483-6. doi: 10.1016/j.jelectrocard.2010.02.009. Epub 2010 Apr 9.

Gender-related patterns of dysprosody in Parkinson disease and correlation between speech variables and motor symptoms

Skodda S, Visser W, Schlegel U.

J Voice. 2011 Jan;25(1):76-82. doi: 10.1016/j.jvoice.2009.07.005. Epub 2010 Apr 9.

Oxidative stress partially contributes to iron-induced α-synuclein aggregation in SK-N-SH cells

Li W, Jiang H, Song N, Xie J.

Neurotox Res. 2011 Apr;19(3):435-42. doi: 10.1007/s12640-010-9187-x. Epub 2010 Apr 10.

Statins: multiple neuroprotective mechanisms in neurodegenerative diseases

Wang Q, Yan J, Chen X, Li J, Yang Y, Weng J, Deng C, Yenari MA.

Exp Neurol. 2011 Jul;230(1):27-34. doi: 10.1016/j.expneurol.2010.04.006. Epub 2010 Apr 18.

Accumulation of non-transferrin-bound iron by neurons, astrocytes, and microglia

Bishop GM, Dang TN, Dringen R, Robinson SR.

Neurotox Res. 2011 Apr;19(3):443-51. doi: 10.1007/s12640-010-9195-x. Epub 2010 Apr 30.

Pharmacological therapy in Parkinson's disease: focus on neuroprotection

Kincses ZT, Vecsei L.

CNS Neurosci Ther. 2011 Oct;17(5):345-67. doi: 10.1111/j.1755-5949.2010.00150.x. Epub 2010 Apr 23.

Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment

Chase TN.

Neurotox Res. 2011 Feb;19(2):266-78. doi: 10.1007/s12640-010-9196-9. Epub 2010 May 15.

Modification of emotional states by bilateral stimulation of the subthalamic nucleus in a patient with Parkinson's disease

Boon P, Dandachi-FitzGerald B, Duits A, Temel Y, Visser-Vandewalle V, van den Hout M.

J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):117-8. doi: 10.1136/jnnp.2009.179234. Epub 2010 Jun 14.

Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases

Perez DI, Gil C, Martinez A.

Med Res Rev. 2011 Nov;31(6):924-54. doi: 10.1002/med.20207. Epub 2010 Jun 23.

Pharmacological significance of triazole scaffold

Kharb R, Sharma PC, Yar MS.

J Enzyme Inhib Med Chem. 2011 Feb;26(1):1-21. doi: 10.3109/14756360903524304. Epub 2010 Jun 28.

How placebos change the patient's brain

Benedetti F, Carlino E, Pollo A.

Neuropsychopharmacology. 2011 Jan;36(1):339-54. doi: 10.1038/npp.2010.81. Epub 2010 Jun 30.

Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment

Eskow Jaunarajs KL, Angoa-Perez M, Kuhn DM, Bishop C.

Neurosci Biobehav Rev. 2011 Jan;35(3):556-64. doi: 10.1016/j.neubiorev.2010.06.007. Epub 2010 Jul 6.

Neuroprotective upregulation of endogenous α-synuclein precedes ubiquitination in cultured dopaminergic neurons

Musgrove RE, King AE, Dickson TC.

Neurotox Res. 2011 May;19(4):592-602. doi: 10.1007/s12640-010-9207-x. Epub 2010 Jul 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias